Effect of Baby Wipe Solutions on Fecal Enzyme-induced Irritation
NCT03346447 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23
Last updated 2018-01-18
Summary
This is a single-center, prospective, single-blind pilot study to determine baby wipe formulations on an adult dermatitis model.
Conditions
- Skin Health
Interventions
- OTHER
-
Artificial Fecal Enzyme
Artificial Fecal enzyme Trypsin/Chymotrypsin mixture
Sponsors & Collaborators
-
Kimberly-Clark Corporation
lead INDUSTRY
Principal Investigators
-
Barry Reece · RCTs
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-09
- Primary Completion
- 2017-10-27
- Completion
- 2017-11-13
Countries
- United States
Study Locations
More Related Trials
-
Gastrointestinal Tolerance Evaluation of an Infant Formula
NCT03307122 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Addition of Structured Lipids in Starter Formulas
NCT02332967 ·Status: COMPLETED ·Phase: NA
-
Tolerance of Healthy Term Infants Fed Infant Formulas #4
NCT01155414 ·Status: COMPLETED ·Phase: PHASE3
-
Feeding Trial in Pediatric Patients
NCT01469117 ·Status: COMPLETED
-
Evaluation of Safety and Efficacy of New Infant Formula in Infantile Colic
NCT01721850 ·Status: TERMINATED ·Phase: NA
-
Acceptability and Gastrointestinal Tolerance of a High-Sn-2 Infant Formula
NCT02598817 ·Status: COMPLETED
-
Study on the Effect of Inulin in Infant Formula on Gut Health
NCT01515644 ·Status: COMPLETED ·Phase: PHASE3
-
Tolerance and Compliance of Infants Fed an Hydrolyzed Infant Formula
NCT01573871 ·Status: COMPLETED ·Phase: PHASE3
-
Study in Unsettled Infants Experiencing Feeding Intolerance
NCT02021058 ·Status: COMPLETED ·Phase: NA
-
Gastrointestinal Tolerance Study of a New Infant Formula
NCT01681355 ·Status: COMPLETED ·Phase: NA
-
Retrospective Review of Amino Acid Formula Use at a Children's Center
NCT03497091 ·Status: COMPLETED
-
Evaluation of Two Regimens, With Healthy Male and Female Babies, Ages 3-6 Months Old, Using Various Assessments.
NCT03457857 ·Status: COMPLETED ·Phase: NA
-
Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants
NCT05868408 ·Status: RECRUITING ·Phase: NA
-
Safety and Tolerance of a Partly Fermented Infant Formula With Prebiotic Oligosaccharides in Healthy Infants
NCT03476889 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Tolerance and Safety of a New Partly Fermented Anti-regurgitation Infant Formula
NCT03371615 ·Status: COMPLETED ·Phase: NA
-
Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula (STELLAR)
NCT04358146 ·Status: RECRUITING ·Phase: NA
-
Can SMOFlipid®, A Composite Parenteral Nutrition Lipid Emulsion, Prevent Progression Of Parenteral Nutrition Associated Liver Disease In Infants?
NCT00793195 ·Status: UNKNOWN ·Phase: PHASE2
-
Impact of Infant Formula on Caregiver-perceived Intolerance
NCT03679234 ·Status: COMPLETED ·Phase: NA
-
Gastrointestinal Symptoms and Tolerance in Infants Fed Goat or Cow's Milk-based Infant Formula
NCT07342972 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Necrotizing Enterocolitis (Nec) and B. Lactis in Premature Babies
NCT00977912 ·Status: TERMINATED ·Phase: NA
-
An Infant Formula Trial on Dietary Management of Infantile Colic
NCT03329222 ·Status: TERMINATED ·Phase: NA
-
Effect of Infant Formulas Containing a New Fat Blend or the New Fat Blend Plus Fiber in Healthy Term Infants
NCT02031003 ·Status: COMPLETED ·Phase: NA
-
Term Infants Fed a Partially Hydrolyzed Whey Protein-Based Formula
NCT04934397 ·Status: TERMINATED ·Phase: NA
-
To Investigate Effects of a New Infant Formula in Healthy Term Chinese Infants
NCT03520764 ·Status: COMPLETED ·Phase: NA
-
Infant Formula Supplemented With Probiotic Microorganisms and/or Prebiotic.
NCT00836771 ·Status: UNKNOWN ·Phase: NA